Cognitive Enhancers for the Treatment of Neuropsychiatric Disorders: Clinical and Preclinical InvestigationsKANTAK, Kathleen; HOFMANN, Stefan G.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, issn 0091-3057, 185 p.Serial Issue

The treatment of cognitive impairment in schizophreniaGOFF, Donald C; HILL, Michele; BARCH, Deanna et al.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 245-253, issn 0091-3057, 9 p.Article

Cognitive enhancers for anxiety disordersHOFMANN, Stefan G; SMITS, Jasper A. J; ASNAANI, Anu et al.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 275-284, issn 0091-3057, 10 p.Article

Cognitive enhancers in the treatment of substance use disorders: Clinical evidenceBRADY, Kathleen T; GRAY, Kevin M; TOLLIVER, Bryan K et al.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 285-294, issn 0091-3057, 10 p.Article

The likelihood of cognitive enhancementLYNCH, Gary; PALMER, Linda C; GALL, Christine M et al.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 116-129, issn 0091-3057, 14 p.Article

Attention-modulating effects of cognitive enhancersLEVIN, Edward D; BUSHNELL, Philip J; REZVANI, Amir H et al.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 146-154, issn 0091-3057, 9 p.Article

Alzheimer's disease and age-related memory decline (preclinical)TERRY, Alvin V; CALLAHAN, Patrick M; HALL, Brandon et al.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 190-210, issn 0091-3057, 21 p.Article

Cognitive enhancers: Focus on modulatory signaling influencing memory consolidationROESLER, Rafael; SCHRÖDER, Nadja.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 155-163, issn 0091-3057, 9 p.Article

The use of cognitive enhancers in animal models of fear extinctionKAPLAN, Gary B; MOORE, Katherine A.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 217-228, issn 0091-3057, 12 p.Article

Drug targets for cognitive enhancement in neuropsychiatric disordersWALLACE, Tanya L; BALLARD, Theresa M; POUZET, Bruno et al.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 130-145, issn 0091-3057, 16 p.Article

Cognitive enhancers for the treatment of ADHDCINNAMON BIDWELL, L; MCCLERNON, F. Joseph; KOLLINS, Scott H et al.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 262-274, issn 0091-3057, 13 p.Article

Cognitive enhancers for facilitating drug cue extinction: Insights from animal modelsBRID AINE NIC DHONNCHADHA; KANTAK, Kathleen M.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 229-244, issn 0091-3057, 16 p.Article

The cholinergic hypothesis of cognitive aging revisited again: Cholinergic functional compensationDUMAS, Julie A; NEWHOUSE, Paul A.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 254-261, issn 0091-3057, 8 p.Article

Putative cognitive enhancers in preclinical models related to schizophrenia: The search for an elusive targetBARAK, Segev; WEINER, Ina.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 164-189, issn 0091-3057, 26 p.Article

Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorderARNSTEN, Amy F. T; PLISZKA, Steven R.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 2, pp 211-216, issn 0091-3057, 6 p.Article